The 19-base-pair enhancer repeat of the human cytomegalovirus immediate-early 1 gene mediates cyclic AMP-and phytohemagglutinin-induced expression in Jurkat T cells. Synergistic activity was observed in the presence of both drugs, suggesting a convergence of the protein kinase A and C pathways on this transcription element. In addition, the immunosuppressive drug cyclosporine strongly reduced the ability of the 19-base-pair repeat to activate gene expression in phytohemagglutinin-stimulated T cells.
expression from the IE1 promoter in PHA-activated Jurkat cells 3-and 23-fold, respectively ( Fig. 1 ). As expected, expression from the IEl enhancer and the 19-bp repeats in Jurkat cells was also activated by cAMP. The IE1 core promoters linked to one and six copies of the 19-bp repeat were activated 6-and 13-fold, respectively, and the IE1 enhancer was activated about 4-fold (Fig. 2) . Since the 19- (Fig. 2) . In particular, the six copies of the 19-bp repeat were activated about 26-and 14-fold by PHA and cAMP, respectively, and about 180-fold in the presence of both drugs. This suggests that the two activation pathways converge on this single transcription element. When the IEl enhancer was tested, an additive effect of cAMP and PHA was observed (Fig. 2) . Since the TEl enhancer contains an array of transcription elements (e.g., Spl-like, KB, NFllike, and CRE) whose activities could be positively or negatively modulated by either signaling pathway, the additive effect probably reflects the combined activities of all elements. The synergistic effect of the T-cell mitogen PHA and the second messenger cAMP on the 19-bp repeat underscores the importance of these signals in the activation of the TEl enhancer and possibly in the reactivation of CMV in T lymphocytes. The modulation of gene expression through the convergence of dual pathways on a single element may be a common theme (23 [2] ) were cloned immediately upstream of the HCMV IEl core promoter (-55 to +7) in front of the structural CAT gene from pAlOCAT2 (19) . The enhancer (-524 to +7) plasmid was obtained from Jay Nelson, San Diego, Calif. For each transfection, 5 jig of plasmid DNA was incubated with 5 x 106 to 10 x 106 cells for 15 min in 2 ml of serum-free Dulbecco modified Eagle medium containing 250 ,ug of DEAE-dextran per ml, 0.1 mM chloroquindiphosphate, and 50 mM Tris hydrochloride at pH 7.3 at 37°C in a shaking water bath. The cells were then washed twice with medium and incubated in RPMI 1640 containing 10% fetal calf serum, 2 mM glutamine, 50 U of penicillin per ml, and 50 jig of streptomycin per ml under 5% CO2 and at 37°C for 40 h. CAT assays were done by standard methods (19) . Each experiment was done three times.
simian CMV (29, 30, 32) , but fail to do so in the context of the HCMV IEl ( Fig. 1) (22) and IL-2Ra (9) promoters, we suggest that contextual sequences are critical for their activity. However, we cannot rule out the possibility that the 18-bp repeats are PHA inducible within their native environment in the IEl enhancer.
Protein binding to the 19-bp repeat. We attempted to identify proteins which may mediate PHA-and cAMPinduced gene expression by analyzing the abilities of nuclear proteins from Jurkat cells grown in the presence of the two drugs to bind to the 19-bp repeat. Nuclear proteins from nontreated and cAMP-treated cells formed one predominant (Fig. 3A, complex d) and three minor (a through c) complexes with a single copy of the 19-bp repeat (Fig. 3A, lanes  1 and 3) . PHA treatment resulted in a decrease in complex a and an increase in complex b (Fig. 3A, lane 2) , which was even more pronounced in extract from PHA-cAMP-stimulated cells (Fig. 3A, lane 4) . This extract also contained protein activity that formed a novel complex e (Fig. 3A, lane  4) . Competition assays suggested that the complexes are sequence specific (data not shown). PHA inducibility of the Jurkat cells was monitored by analyzing KB binding activity. As expected (29) , novel binding activity to the 18-bp repeat (KB site) was detected after PHA treatment (Fig. 3C, binding activity was related to AP1, we tested AP1 binding sites which differed from the functional CRE core in the 19-bp repeat by a single nucleotide (Fig. 2) . No binding was detected in extract from unstimulated or PHA-stimulated Jurkat cells (Fig. 3B) , suggesting that these cells do not contain AP1 activity.
Since CREs are recognized by dimeric forms of transcription factors (20, 26) containing protein kinase A and C target sequences (18), two models, both of which are compatible with our binding data, could account for the synergistic action of PHA and cAMP. Covalent modification of the preexisting CREB protein (42) by protein kinase A or C could result in the transcriptional stimulation observed with either cAMP or PHA alone. Phosphorylation with both protein kinases could result in a more potent transcription factor. Alternatively, cAMP and PHA could act through different transcription factors, and the cooperative binding of heterodimers to CREs would lead to enhanced transcription.
CsA-reduced PHA-induced gene expression. Clinical observations suggest that the rate of HCMV infection in organ transplant patients has declined since the introdudtion of CsA as an immunosuppressive agent (4, 5) . Since CsA affects the initial mitogen-induced phase of T-cell activation (35) and suppresses the activation of several T-cell genes on the transcriptional level (8, 11-13, 24, 36, 39, 43) , we studied its ability to block PHA-activated expression from the IEl enhancer and the 19-bp repeat. CsA did not affect the basal activity of any of the constructs tested (data not shown). However, the PHA-induced activity of the IEl enhancer was reduced by 45% when the two drugs were administered simultaneously (Fig. 1) . Activation of the 18-bp repeat, which in the context of the (18bp)3 plasmid responds only marginally to PHA, was also in part suppressed by CsA (21) . The resulting protein-DNA complexes were separated in a 4% polyacrylamide gel containing 50 mM Tris, 380 mM glycine, and 2 mM EDTA as gel and running buffer as described previously (21) . Nuclear extracts were prepared as described previously (6, 21) from 5 x 108 cells grown in the presence or absence of drugs as indicated.
enhancer. The PHA-induced activities of one and six copies of the 19-bp repeats were reduced in the presence of CsA by 50 and 80%, respectively (Fig. 1) . PHA-induced protein binding to the 19-bp repeat did not change upon treatment with CsA (data not shown). Although the mode of action of CsA is not known, it can be suggested that CsA interferes with a PHA-induced pathway that activates transcription from the IEl enhancer through the 19-bp repeat. Similarly, CsA abolished the activity of the T-cell-inducible element NF-AT (13) , which has been found in the interleukin-2 gene and has no sequence similarity to the 19-bp repeat. This suggests that CsA may inhibit the function of a proximal member of the signal transmission cascade leading from the antigen receptor to the nucleus.
